Literature DB >> 20368428

Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing.

Michael Shtutman1, Anil Maliyekkel, Yu Shao, C Steven Carmack, Mirza Baig, Natalie Warholic, Kelly Cole, Eugenia V Broude, Timothy T Harkins, Ye Ding, Igor B Roninson.   

Abstract

As a general strategy for function-based gene identification, an shRNA library containing approximately 150 shRNAs per gene was enzymatically generated from normalized (reduced-redundance) human cDNA. The library was constructed in an inducible lentiviral vector, enabling propagation of growth-inhibiting shRNAs and controlled activity measurements. RNAi activities were measured for 101 shRNA clones representing 100 human genes and for 201 shRNAs derived from a firefly luciferase gene. Structure-activity analysis of these two datasets yielded a set of structural criteria for shRNA efficacy, increasing the frequencies of active shRNAs up to 5-fold relative to random sampling. The same library was used to select shRNAs that inhibit breast carcinoma cell growth by targeting potential oncogenes. Genes targeted by the selected shRNAs were enriched for 10 pathways, 9 of which have been previously associated with various cancers, cell cycle progression, or apoptosis. One hundred nineteen genes, enriched through this selection and represented by two to six shRNAs each, were identified as potential cancer drug targets. Short interfering RNAs against 19 of 22 tested genes in this group inhibited cell growth, validating the efficiency of this strategy for high-throughput target gene identification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20368428      PMCID: PMC2867740          DOI: 10.1073/pnas.1003055107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Restriction enzyme-generated siRNA (REGS) vectors and libraries.

Authors:  George Sen; Tom S Wehrman; Jason W Myers; Helen M Blau
Journal:  Nat Genet       Date:  2004-01-04       Impact factor: 38.330

Review 2.  On the art of identifying effective and specific siRNAs.

Authors:  Yi Pei; Thomas Tuschl
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

3.  Effect of target secondary structure on RNAi efficiency.

Authors:  Yu Shao; Chi Yu Chan; Anil Maliyekkel; Charles E Lawrence; Igor B Roninson; Ye Ding
Journal:  RNA       Date:  2007-08-07       Impact factor: 4.942

4.  A systems biology approach for pathway level analysis.

Authors:  Sorin Draghici; Purvesh Khatri; Adi Laurentiu Tarca; Kashyap Amin; Arina Done; Calin Voichita; Constantin Georgescu; Roberto Romero
Journal:  Genome Res       Date:  2007-09-04       Impact factor: 9.043

5.  Construction of equalized short hairpin RNA library from human brain cDNA.

Authors:  Lei Xu; Jingqi Li; Li Liu; Lixia Lu; Jingxia Gao; Xueli Li
Journal:  J Biotechnol       Date:  2006-11-25       Impact factor: 3.307

6.  Cell cycle arrest drastically extends the duration of gene silencing after transient expression of short hairpin RNA.

Authors:  Anil Maliyekkel; Brian M Davis; Igor B Roninson
Journal:  Cell Cycle       Date:  2006-10-16       Impact factor: 4.534

7.  Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements.

Authors:  Thomas Primiano; Mirza Baig; Anil Maliyekkel; Bey Dih Chang; Stacey Fellars; Justin Sadhu; Sergey A Axenovich; Tatyana A Holzmayer; Igor B Roninson
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

8.  PCR-based generation of shRNA libraries from cDNAs.

Authors:  Cheng Du; Baosheng Ge; Zhongfeng Liu; Kai Fu; Wing C Chan; Timothy W McKeithan
Journal:  BMC Biotechnol       Date:  2006-06-21       Impact factor: 2.563

9.  A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway.

Authors:  Jasper Mullenders; Armida W M Fabius; Mandy Madiredjo; René Bernards; Roderick L Beijersbergen
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

10.  Cancer proliferation gene discovery through functional genomics.

Authors:  Michael R Schlabach; Ji Luo; Nicole L Solimini; Guang Hu; Qikai Xu; Mamie Z Li; Zhenming Zhao; Agata Smogorzewska; Mathew E Sowa; Xiaolu L Ang; Thomas F Westbrook; Anthony C Liang; Kenneth Chang; Jennifer A Hackett; J Wade Harper; Gregory J Hannon; Stephen J Elledge
Journal:  Science       Date:  2008-02-01       Impact factor: 47.728

View more
  10 in total

1.  A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulation.

Authors:  Xiaofeng Jiang; Hui Pan; Joseph F Nabhan; Ramaswamy Krishnan; Cynthia Koziol-White; Reynold A Panettieri; Quan Lu
Journal:  FASEB J       Date:  2012-01-25       Impact factor: 5.191

2.  Effects of conditional depletion of topoisomerase II on cell cycle progression in mammalian cells.

Authors:  Ruth E Gonzalez; Chang-Uk Lim; Kelly Cole; Christine Hanko Bianchini; Gary P Schools; Brian E Davis; Ikuo Wada; Igor B Roninson; Eugenia V Broude
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

3.  Size unbiased representative enzymatically generated RNAi (SURER) library and application for RNAi therapeutic screens.

Authors:  Tiejun Li; York Yuanyuan Zhu; Li Chen; Yuncheng Sun; Jian Yuan; Michael Graham; Peter French
Journal:  Nucleic Acid Ther       Date:  2014-12-10       Impact factor: 5.486

4.  Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1.

Authors:  Michael Shtutman; Mirza Baig; Elina Levina; Gregory Hurteau; Chang-Uk Lim; Eugenia Broude; Mikhail Nikiforov; Timothy T Harkins; C Steven Carmack; Ye Ding; Felix Wieland; Ralph Buttyan; Igor B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

5.  Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.

Authors:  Charles C Weige; Marc R Birtwistle; Himel Mallick; Nengjun Yi; Zuzana Berrong; Emily Cloessner; Keely Duff; Josephine Tidwell; Megan Clendenning; Brent Wilkerson; Christopher Farrell; Fred Bunz; Hao Ji; Michael Shtutman; Kim E Creek; Carolyn E Banister; Phillip J Buckhaults
Journal:  Mol Cancer Res       Date:  2014-04-17       Impact factor: 5.852

6.  Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.

Authors:  Elina Levina; Hao Ji; Mengqiang Chen; Mirza Baig; David Oliver; Patrice Ohouo; Chang-uk Lim; Garry Schools; Steven Carmack; Ye Ding; Eugenia V Broude; Igor B Roninson; Ralph Buttyan; Michael Shtutman
Journal:  Oncotarget       Date:  2015-05-30

7.  NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy.

Authors:  Yu-Ling Tsai; Kuo-Feng Hua; Ann Chen; Chyou-Wei Wei; Wen-Shiang Chen; Cheng-Yeu Wu; Ching-Liang Chu; Yung-Luen Yu; Chia-Wen Lo; Shuk-Man Ka
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

8.  Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen.

Authors:  David Oliver; Hao Ji; Piaomu Liu; Alexander Gasparian; Ellen Gardiner; Samuel Lee; Adrian Zenteno; Lillian O Perinskaya; Mengqian Chen; Phillip Buckhaults; Eugenia Broude; Michael D Wyatt; Homayoun Valafar; Edsel Peña; Michael Shtutman
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

9.  Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir.

Authors:  Biswajit Das; Curtis Dobrowolski; Benjamin Luttge; Saba Valadkhan; Nicolas Chomont; Rowena Johnston; Peter Bacchetti; Rebecca Hoh; Monica Gandhi; Steven G Deeks; Eileen Scully; Jonathan Karn
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

10.  Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis.

Authors:  Qing Li; Ahmad F Karim; Xuedong Ding; Biswajit Das; Curtis Dobrowolski; Richard M Gibson; Miguel E Quiñones-Mateu; Jonathan Karn; Roxana E Rojas
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.